NATIONAL JEWISH HEALTH

EIN: 742044647 501(c)(3) Health Care

DENVER, CO

Total Revenue
$375,353,154
Total Expenses
$383,108,771
Total Assets
$390,669,000
Net Assets
$254,240,000
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1978
Legal Domicile
CO
Principal Officer
Christine Forkner
Phone
3033884461
Tax Period
2024-07-01 to 2025-06-30

NATIONAL JEWISH HEALTH, founded in 1978, is a major nonprofit in the Health Care sector that reported $375.4M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year.

Mission

National Jewish Health's mission since 1899 is to heal, discover and educate as a preeminent healthcare institution. We serve by providing the best integrated and innovative care for patients and their families; by understanding and finding cures for the diseases we research; and, by educating and training the next generation of healthcare professionals to be leaders in medicine and science.

Program Service Accomplishments

Program 1
Expenses: $243,412,228 Revenue: $233,308,135

National Jewish Health is a nationally recognized, academic medical center with specialized expertise in the evaluation and management of respiratory, cardiac, allergic and immunologic diseases...

Read more

National Jewish Health is a nationally recognized, academic medical center with specialized expertise in the evaluation and management of respiratory, cardiac, allergic and immunologic diseases. National Jewish Health serves as a referral center for patients across the United States, particularly for those patients with diseases that are exceptionally difficult to diagnose and/or treat. National Jewish Health provides care to adult and pediatric patients on both an inpatient and outpatient basis and offers a comprehensive spectrum of clinical services. Clinical services include but are not limited to: pulmonary, critical care and sleep medicine, allergy /immunology, occupational and environmental health sciences, cardiology, pulmonary, hypertension, rheumatology, gastroenterology, infectious disease and mycobacterial infections, cystic fibrosis, neurology, neuromuscular medicine and ALS, thoracic surgery, immediate care, otolaryngology and oncology. In the fiscal year ended June 30, 2025, National Jewish Health provided over 120,285 outpatient visits. Additionally, our physicians provided over 6,011 inpatient encounters, primarily critical care services, pulmonary consultative service and hospitalist services, at multiple facilities across metropolitan Denver, including the National Jewish Health main campus. Our patients come from virtually every state across the United States, with residents from our Colorado community constituting the largest single group. National Jewish Health was founded under the motto, "None may enter who can pay; None can pay who enter." While today, National Jewish Health accepts paying patients, a significant amount of charity care is provided and all appointments are offered on a first come, first serve basis regardless of the ability to pay. National Jewish Health continues to adapt its clinical programs to meet the unique needs of the changing healthcare landscape, like providing Chronic Care ManagementTM, multi-disciplinary clinics for patients suffering and recovering from long COVID, and an Immediate Care clinic for adults and kids with unexpected illnesses and minor injuries. National Jewish Health has collaborated with local hospitals to provide a combined state of the art outpatient clinic and inpatient care setting.

Program 2
Expenses: $69,042,170 Revenue: $5,091,866

National Jewish Health receives various types of grants. In addition to the above, National Jewish Health received $56,915,359 of funding through grants which are included in Part VIII (revenues)...

Read more

National Jewish Health receives various types of grants. In addition to the above, National Jewish Health received $56,915,359 of funding through grants which are included in Part VIII (revenues), lines 1e and 1f. National Jewish Health conducts extensive basic, translational and clinical biomedical research. In addition to translational research programs in its areas of clinical specialties, National Jewish Health conducts research in basic immunology, genetics, proteomics, cell biology, signal transduction, structural biology, cancer biology, and oxidant biology. Research activities have resulted in a number of scientific discoveries that have improved care for patients worldwide. National Jewish received a federal contract renewal to continue funding our COPDGene research and network. Funds for National Jewish Health's research are provided by grants from private and governmental agencies which include the National Institute of Health (NIH), the Department of Defense (DOD), National Science Foundation (NSF) and charitable contributions from private industry.

Program 3
Expenses: $14,339,028 Revenue: $332,322

National Jewish Health is the nations' largest nonprofit provider of telephonic and technology-based commercial tobacco cessation services, delivering evidence-based, personalized telephone and...

Read more

National Jewish Health is the nations' largest nonprofit provider of telephonic and technology-based commercial tobacco cessation services, delivering evidence-based, personalized telephone and online coaching programs in 23 states and a variety of health plans, employer groups and wellness companies. The state grant contract revenue of $17,140,017 is included in Part VIII, line 1e, while the rest of the revenue is reported in section 4c above. Since the development of our Quitline program in 2002, National Jewish Health has assisted more than 2.5 million people with their quit attempts. In FY25, we launched a new mobile application to support My Life, My Quit 2.0, enhancing access and engagement for youth participants seeking cessation support. In tandem, we introduced a refreshed QuitLogix(R) 3.0 platform to strengthen the participant experience, streamline navigation, and expand functionality across all participating states. The Quitline program follows the best practices and industry standards published by the Centers for Disease Control and Prevention (CDC) and North American Quitline Consortium (NAQC). National Jewish Health's protocols are research- and evidence-based. The Quitline is staffed by more than 80 professionals who are devoted to commercial tobacco use prevention and cessation. The Tobacco Cessation Coaches undergo rigorous training that enables them to tailor their coaching services based on participant needs using our proven-successful coaching model. For each person who reaches out to the Quitline for help, the coaches immediately engage them in their quit journey to foster success, and our results demonstrate our proven track record. Our surveys, conducted by an independent third party, show that individuals who receive our evidence-based coaching services and use cessation medications have a 37% long-term quit rate, one of the best quit rates in the nation. nation.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $107,173,193
Program Service Revenue $253,324,980
Investment Income $13,513,886
Other Revenue $1,341,095
TOTAL REVENUE $375,353,154

Expense Breakdown

Grants Paid $0
Salaries & Benefits $193,782,539
Fundraising Expenses $11,460,553
Program Expenses $339,288,323
Other Expenses $188,970,432
TOTAL EXPENSES $383,108,771

Year-over-Year Comparison

2024 2023 Change
Revenue $375,353,154 $401,084,397 -0.1%
Expenses $383,108,771 $399,121,001 0.0%
Net Income $-7,755,617 $1,963,396 -5.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
45
Independent Members
44
Employees
2099
Volunteers
4

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$3,061,825
Total Directors
45
$2,402,798
Key Employees
7
$3,860,580
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Michael S Salem MD President and CEO, BOD Member 50
Officer Director
$2,402,798 $0 $2,402,798
Gregory Downey MD EVP Academic Affairs & Provost 50
Key Emp
$873,074 $0 $873,074
Rao Mushtaq MD Assistant Professor, Division of Oncology 50
Highest
$732,911 $0 $732,911
Jeffrey King MD Chief, Division of Gastroenterology 50
Highest
$670,958 $0 $670,958
Christine K Forkner EVP Corproate Affairs and CFO, Ass't Treasurer 50
Officer
$659,027 $0 $659,027
Pranav Periyalwar MD Assistant Professor, Division of Gastroenterology 50
Highest
$639,617 $0 $639,617
Stephen Frankel MD EVP Clincial Affairs & CCO 50
Key Emp
$631,757 $0 $631,757
Kevin K Brown MD Chair, Department of Medicine 50
Key Emp
$590,087 $0 $590,087
Raphael Sung MD Associate Professor, Division of Cardiology 50
Highest
$572,592 $0 $572,592
Glenn Hirsch MD Chief, Division of Cardiology 50
Highest
$532,407 $0 $532,407
Pamela L Zeitlin MD PhD Chair, Department of Pediatrics 50
Key Emp
$501,154 $0 $501,154
Lisa Tadiri Vice President Development 50
Key Emp
$494,203 $0 $494,203
Seth Kligerman MD Chair, Department of Radiology 50
Key Emp
$386,893 $0 $386,893
Kristi Melton VP Clinical Business Operations 50
Key Emp
$383,412 $0 $383,412
Stephen W Arent Lifetime Member, BOD 2
Director
$0 $0 $0
Richard N Baer Member, BOD 2
Director
$0 $0 $0
Geoff H Barker Member, BOD 2
Director
$0 $0 $0
James B Berenbaum Member, BOD 2
Director
$0 $0 $0
Norman Brownstein Lifetime Member, BOD 2
Director
$0 $0 $0
Robin D Chotin Vice Chair and Secretary, BOD 2
Director
$0 $0 $0
Ross S Chotin Member, BOD 2
Director
$0 $0 $0
Warren P Cohen Member, BOD 2
Director
$0 $0 $0
Steven C Demby Member, BOD 2
Director
$0 $0 $0
R Stanton Dodge Member, BOD 2
Director
$0 $0 $0
David Engleberg Lifetime Member, BOD 2
Director
$0 $0 $0
Brad C Farber Member, BOD 2
Director
$0 $0 $0
Daniel J Feiner Member, BOD 2
Director
$0 $0 $0
Michael A Feiner Member, BOD 2
Director
$0 $0 $0
Thomas A Gart Member, BOD 2
Director
$0 $0 $0
Lawrence P Gelfond Lifetime Member, BOD 2
Director
$0 $0 $0
Roger A Gibson Member, BOD 2
Director
$0 $0 $0
Charles Gwirtsman Member, BOD 2
Director
$0 $0 $0
Robin S Hickenlooper Member, BOD 2
Director
$0 $0 $0
A Barry Hirschfeld Lifetime Member, BOD 2
Director
$0 $0 $0
Kristen Holtzman Member, BOD 2
Director
$0 $0 $0
Lewis M Kling Member, BOD 2
Director
$0 $0 $0
Steven D Kris Member, BOD 2
Director
$0 $0 $0
Bradley A Levin Member, BOD 2
Director
$0 $0 $0
Bonnie Mandarich Member, BOD 2
Director
$0 $0 $0
Connie G McArthur Member, BOD 2
Director
$0 $0 $0
Scott Mitchell Member, BOD 2
Director
$0 $0 $0
Marvin I Moskowitz Member, BOD 2
Director
$0 $0 $0
Brian J Parks Member, BOD 2
Director
$0 $0 $0
Samuel Rascoff Member, BOD 2
Director
$0 $0 $0
Blair E Richardson Member, BOD 2
Director
$0 $0 $0
Edward A Robinson Lifetime Member, BOD 2
Director
$0 $0 $0
Meyer M Saltzman Lifetime Member, BOD 2
Director
$0 $0 $0
John Sampson Member, BOD 2
Director
$0 $0 $0
Richard A Schierburg Lifetime Member, BOD 2
Director
$0 $0 $0
Michael K Schonbrun Member, BOD 2
Director
$0 $0 $0
Martin Semple Lifetime Member, BOD 2
Director
$0 $0 $0
Jim Sheets Member, BOD 2
Director
$0 $0 $0
Stephen B Siegel Member, BOD 2
Director
$0 $0 $0
Wendy M Siegel Member, BOD 2
Director
$0 $0 $0
Donald A Silversmith Member, BOD 2
Director
$0 $0 $0
Marc D Steron Member, BOD 2
Director
$0 $0 $0
Debra M Tuchman Member, BOD 2
Director
$0 $0 $0
Evan H Zucker Member, BOD 2
Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $375,353,154 $383,108,771 $390,669,000 $-7,755,617
2024 No data No data No data No data
2023 $348,531,726 $370,065,540 $417,131,000 $-21,533,814
2022 $358,276,772 $346,514,824 $438,155,000 $11,761,948
2021 $377,230,660 $341,524,571 $453,973,000 $35,706,089
2020 $331,534,080 $313,987,559 $349,926,000 $17,546,521
2019 $298,202,040 $284,109,927 $304,229,000 $14,092,113
2018 $278,258,147 $261,433,024 $301,872,000 $16,825,123
Explore More Nonprofits
Top 100 Nonprofits in Colorado Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare NATIONAL JEWISH HEALTH with other nonprofits in Colorado and across the country.